Idiopathic hyperaldosteronism (IHA) represents about 65% of primary hyperaldosteronism cases. Although mineralocorticoid receptor antagonists (MRAs) are the standard first-line treatment, they are often limited by adverse effects. Superselective adrenal artery embolization (SAAE) has been utilized for IHA over the last decade, yet comparative studies against MRAs are lacking. The objective of this study is to compare the safety and efficacy of SAAE and MRA to determine the feasibility of SAAE in treating IHA.
Aged from 15 to 60 with no limits in sex;
Patients are diagnosed with primary aldosteronism according to the criteria of the 2016 Endocrine Society guidelines;
Sub-typing diagnosis confirmed idiopathic hyperaldosteronism;
Patients or their legal representatives have to sign written informed consent approved by the ethics committee.
Unilateral adrenal hyperplasia;
Renal insufficiency with an estimated glomerular filtration rate (based on the modification of diet in renal disease criteria) <45 ml/min/1.73 m², and/or serum creatinine >176 μmol/L；
Hemorrhagic or ischemic stroke, endovascular stent implantation and myocardial infarction within the previous 3 months;
Severe contrast agent allergy;
Chinese Academy of Medical Sciences, Fuwai Hospital
Lead sponsor
Second Affiliated Hospital of Nanchang University
Collaborator
First Affiliated Hospital of Chengdu Medical College
Collaborator